Profiel
Paul Sohn is currently the Chairman at Argentum Pharmaceuticals LLC, the Chief Investment Officer at Mont Alto Capital LLC, and the Co-Chief Investment Officer at HPF LLC.
He previously worked as a Portfolio Manager at Kingdon Capital Management LLC.
He received his undergraduate degree from Yale University in 1999.
Actieve functies van Paul Sohn
| Bedrijven | Functie | Begin |
|---|---|---|
Mont Alto Capital LLC
Mont Alto Capital LLC Investment ManagersFinance Mont Alto Capital invests in companies located in the United States. The firm focuses on companies operating in a broad range of sectors. It provides financing for early and growth-stage transactions. | Chief Investment Officer | 01-01-2015 |
Argentum Pharmaceuticals
Argentum Pharmaceuticals Pharmaceuticals: GenericHealth Technology Develops and supplies generic drugs | Voorzitter | 01-01-2015 |
Eerdere bekende functies van Paul Sohn
| Bedrijven | Functie | Einde |
|---|---|---|
Kingdon Capital Management LLC
Kingdon Capital Management LLC Investment ManagersFinance Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry. | Analyst-Equity | - |
Opleiding van Paul Sohn
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Kingdon Capital Management LLC
Kingdon Capital Management LLC Investment ManagersFinance Kingdon aims to achieve attractive risk-adjusted returns across all market cycles. The firm adheres to research driven process, investing across geographies, industries and asset classes to find the best use of capital. They offer two investment strategies: a global long/short equity strategy (Flagship Strategy) and a global long/short healthcare strategy (Healthcare Strategy). The Flagship Strategy consists of thematic, idiosyncratic and opportunistic investments with diversified return drivers and an emphasis on liquidity. The Healthcare Strategy primarily invests in the global healthcare industry. | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Argentum Pharmaceuticals
Argentum Pharmaceuticals Pharmaceuticals: GenericHealth Technology Develops and supplies generic drugs | Health Technology |
Mont Alto Capital LLC
Mont Alto Capital LLC Investment ManagersFinance Mont Alto Capital invests in companies located in the United States. The firm focuses on companies operating in a broad range of sectors. It provides financing for early and growth-stage transactions. | Finance |
















